Article Versions Notes

Xia X, Zhang Z, Zhang J, Feng K, Wang Y, Lee RJ, Yao S, Wu M. Synergistic Co-Delivery of siFGF2 and Doxorubicin via QTPlus Nanoparticles for Enhanced Breast Cancer Therapy. Pharmaceutics. 2026; 18(5):589. https://doi.org/10.3390/pharmaceutics18050589

Xia, Xiaohan, Zhongkun Zhang, Jingjing Zhang, Kaixin Feng, Yufei Wang, Robert J. Lee, Siyu Yao, and Min Wu. 2026. "Synergistic Co-Delivery of siFGF2 and Doxorubicin via QTPlus Nanoparticles for Enhanced Breast Cancer Therapy" Pharmaceutics 18, no. 5: 589. https://doi.org/10.3390/pharmaceutics18050589

Xia, X., Zhang, Z., Zhang, J., Feng, K., Wang, Y., Lee, R. J., Yao, S., & Wu, M. (2026). Synergistic Co-Delivery of siFGF2 and Doxorubicin via QTPlus Nanoparticles for Enhanced Breast Cancer Therapy. Pharmaceutics, 18(5), 589. https://doi.org/10.3390/pharmaceutics18050589